Elekta (OTCMKTS:EKTAY) Stock Price Down 13.2% – What’s Next?

Elekta AB (OTCMKTS:EKTAY)’s share price traded down 13.2% during mid-day trading on Friday . The stock traded as low as $5.7530 and last traded at $5.7530. 267 shares changed hands during trading, a decline of 89% from the average session volume of 2,419 shares. The stock had previously closed at $6.63.

Elekta Trading Up 0.8%

The firm has a market capitalization of $2.12 billion, a PE ratio of -35.96 and a beta of 1.01. The company’s 50-day moving average price is $6.01 and its 200-day moving average price is $5.99. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.73 and a current ratio of 0.95.

Elekta (OTCMKTS:EKTAY) last released its quarterly earnings data on Thursday, May 28th. The company reported $0.06 earnings per share (EPS) for the quarter. The business had revenue of $521.00 million during the quarter. Elekta had a negative net margin of 3.32% and a positive return on equity of 10.67%. On average, sell-side analysts expect that Elekta AB will post 0.44 earnings per share for the current year.

Elekta Company Profile

Elekta is a global medical technology company specializing in the development, manufacture and support of precision radiation therapy and radiosurgery equipment. Its products and services aim to improve patient outcomes in oncology and neurosurgery by combining advanced hardware, software and clinical workflow solutions. Elekta’s offerings are designed to address a broad range of cancer types and brain disorders through targeted, image-guided treatments.

The company’s core product portfolio includes linear accelerators for external beam radiation therapy, stereotactic radiosurgery systems such as the renowned Gamma Knife platform, and brachytherapy solutions for internal radiation treatment.